|
|
Volumn 28, Issue 4, 2008, Pages 434-435
|
|
Is routine monitoring of hepatic and renal function beneficial following single-dose methotrexate treatment for ectopic pregnancy? A 4-year review of experience from a teaching hospital
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ASPARTATE AMINOTRANSFERASE;
CREATININE;
DIHYDROFOLATE REDUCTASE;
ELECTROLYTE;
METHOTREXATE;
UREA;
ABDOMINAL PAIN;
ARTICLE;
BLOOD CELL COUNT;
BONE MARROW SUPPRESSION;
CREATININE BLOOD LEVEL;
DRUG EXCRETION;
DRUG METABOLISM;
ECTOPIC PREGNANCY;
ELECTROLYTE BLOOD LEVEL;
FEMALE;
FOLLOW UP;
HUMAN;
KIDNEY DYSFUNCTION;
KIDNEY FUNCTION TEST;
LIVER DYSFUNCTION;
LIVER FUNCTION TEST;
MAJOR CLINICAL STUDY;
MONITORING;
MUCOSA INFLAMMATION;
NAUSEA;
PRIORITY JOURNAL;
SINGLE DRUG DOSE;
UREA BLOOD LEVEL;
ABORTIFACIENT AGENTS, NONSTEROIDAL;
DRUG MONITORING;
FEMALE;
HUMANS;
KIDNEY;
KIDNEY FUNCTION TESTS;
LIVER;
LIVER FUNCTION TESTS;
METHOTREXATE;
PREGNANCY;
PREGNANCY, ECTOPIC;
|
|
EID: 46749125471
PISSN: 01443615
EISSN: 13646893
Source Type: Journal
DOI: 10.1080/01443610802163773 Document Type: Article |
|
Times cited : (8)
|
|
References (5)
|
